Notícias

Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has ...

Pulmonary fibrosis is a chronic, fibrotic lung disease affecting 3 million people worldwide. The ACE2/Ang-(1–7)/MasR axis is of interest in...

We aimed to investigate the association between fluoxetine use and the survival of hospitalised coronavirus disease (COVID-19) pneumonia patients. This...

The emergence of SARS-CoV-2 variants of concern suggests viral adaptation to enhance human-to-human transmission1,2. Although much effort has focused on...

Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic,...

A ABIFINA, juntamente com outras 15 entidades da área da saúde, assina um manifesto em defesa da Agência Nacional de...

O ano de 2021 nos mostrou que, à luz da ciência, podemos enfrentar os mais difíceis obstáculos. É com essa...

A BLAU FARMACÊUTICA S.A., uma das principais indústrias farmacêuticas da América Latina focada na produção de medicamentos de alta complexidade...

The coronavirus disease 2019 (COVID-19) pandemic caused by the coronavirus—severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause global...

As the latest identified novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC), the influence of Omicron...

Macrodomains are a class of conserved ADP-ribosylhydrolases expressed by viruses of pandemic concern, including coronaviruses and alphaviruses. Viral macrodomains are...